Free Trial

Nutex Health (NASDAQ:NUTX) Shares Up 9.8% - Should You Buy?

Nutex Health logo with Medical background

Key Points

  • Nutex Health's shares rose by 9.8% on Thursday, with the stock last trading at $91.42 after hitting a previous close of $83.24.
  • Wall Street analysts show mixed sentiments, with two firms maintaining a "Buy" rating while Wall Street Zen downgraded the stock from "buy" to "hold".
  • The company has a market capitalization of $511.52 million and a PE ratio of 7.74, indicating a potentially undervalued status.
  • Five stocks we like better than Nutex Health.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) shares shot up 9.8% on Thursday . The stock traded as high as $91.50 and last traded at $91.42. 101,939 shares changed hands during trading, a decline of 33% from the average session volume of 151,860 shares. The stock had previously closed at $83.24.

Wall Street Analyst Weigh In

Several brokerages have recently commented on NUTX. Wall Street Zen cut Nutex Health from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Benchmark raised their target price on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th. Finally, Maxim Group set a $205.00 target price on Nutex Health and gave the stock a "buy" rating in a research report on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $252.50.

Read Our Latest Research Report on NUTX

Nutex Health Trading Up 10.5%

The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The company has a fifty day moving average of $97.22 and a 200-day moving average of $104.08. The firm has a market capitalization of $511.52 million, a PE ratio of 7.74 and a beta of -0.17.

Institutional Trading of Nutex Health

Several hedge funds and other institutional investors have recently modified their holdings of NUTX. BNP Paribas Financial Markets raised its holdings in shares of Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock worth $40,000 after acquiring an additional 290 shares in the last quarter. Ameritas Investment Partners Inc. bought a new position in Nutex Health during the second quarter valued at about $44,000. Bank of America Corp DE raised its holdings in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Police & Firemen s Retirement System of New Jersey bought a new position in Nutex Health during the second quarter valued at about $97,000. Finally, KLP Kapitalforvaltning AS bought a new position in Nutex Health during the second quarter valued at about $112,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.